Hearts On Fire Selects TBWA\Chiat\Day New York Agency As Creative Partner for Global Advertising
TBWA Announces Key Executive Appointments and New Regional Structure
ERYTECH Appoints New Independent Board Member
Street gushes over Alzheimer's drug, but some worry about overreaction
Actavis' transformation to a wide-moat company following its deal with Allergan represents a good buying opportunity for long-term investors.
GlaxoSmithKline GSK reported solid second-quarter results on Wednesday that were largely in line with our expectations, and we don't anticipate any changes to our fair value estimate. Sales increased 10% from the prior year driven by strong sales of asthma medicine Advair, diabetes medicine ...
Merck's reinvigorated pipeline and Sanofi's minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.
Top managers continue to find new opportunities, while taking full advantage of a rising stock market to book some gains.
American depositary receipts provide individual investors with a way to invest abroad using U.S. exchanges and U.S. dollars.